Ampa
Overview
Ampa is a neurotechnology company that makes Ampa One, a portable, lightweight, camera-guided, FDA-cleared TMS device. Ampa One is available via subscription with no upfront cost or per-treatment fee. Ampa One is pioneering One-Day TMS treatment and is designed to make an established therapy practical for practices that previously could not offer it. Founded by researchers who helped pioneer modern TMS protocols, Ampa's mission is to enable one billion remissions from mental and neurological disorders.
More in Neurotechnology
Latest industry news
A Female PhD Pioneer Leads a Brain-Computer Interface Startup to a Landmark IPO
2026-09-08 · Industry
At-Home Neuromodulation Is Coming for Depression — and It's Closer Than You Think
2026-09-07 · Product
New Accelerator Seeks to Bring Neurotech Startups From Lab to Market Faster
2026-09-06 · Industry
China Accelerates Its Brain-Computer Interface Ambitions in a Major National Push
2026-09-05 · Industry
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →